YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Pharmacokinetics and Hepatic Safety of EGCG

Phase 1

Completed

Conditions: Uterine Fibroids

Interventions: Dietary Supplement: Epigallocatechin gallate (EGCG)
Drug: Clomiphene Citrate
Drug: Letrozole

First Posted Date: 2019-11-26

Last Posted Date: 2023-06-05

Lead Sponsor: Yale University

Target Recruit Count: 39

Registration Number: NCT04177693

Locations: 🇺🇸
Johns Hopkins Medicine, Baltimore, Maryland, United States

Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis

Phase 3

Active, not recruiting

Conditions: Infertility
Endometriosis

Interventions: Other: Placebo or SOC IVF
Drug: Elagolix 200 MG

First Posted Date: 2019-11-21

Last Posted Date: 2024-04-19

Lead Sponsor: Yale University

Target Recruit Count: 112

Registration Number: NCT04173169

Locations: 🇺🇸
Yale School of Medicine Dept.of Ob/Gyn & Reproductive Sciences, New Haven, Connecticut, United States
🇺🇸
University of Colorado Department of Obstetrics & Gynecology, Aurora, Colorado, United States
🇺🇸
Duke Fertility, Morrisville, North Carolina, United States

and more 2 locations

A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL)

Phase 1

Completed

Conditions: CTCL

Interventions: Drug: ABT-199 (venetoclax)

First Posted Date: 2019-11-21

Last Posted Date: 2021-06-25

Lead Sponsor: Yale University

Target Recruit Count: 4

Registration Number: NCT04171791

Locations: 🇺🇸
Yale New Haven Hospital / Smilow Cancer Center, New Haven, Connecticut, United States

Evaluating the Feasibility and Efficacy of a Real-time Smoking Intervention Using Wearable Technology

Not Applicable

Completed

Conditions: Tobacco Use Cessation

Interventions: Behavioral: Real-Time Smoking Intervention
Behavioral: Standard Treatment

First Posted Date: 2019-11-21

Last Posted Date: 2023-02-13

Lead Sponsor: Yale University

Target Recruit Count: 58

Registration Number: NCT04172623

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Ultrasound Guided Emergency Physician Performed Erector Spinae Nerve Block for Rib Fracture Analgesia

Phase 1

Not yet recruiting

Conditions: Rib Fractures

Interventions: Drug: ESP block with bupivacaine
Other: Saline control/sham injection

First Posted Date: 2019-11-19

Last Posted Date: 2024-05-24

Lead Sponsor: Yale University

Target Recruit Count: 72

Registration Number: NCT04168710

Operative Versus Non-Operative Management for Appendicitis With Abscess or Phlegmon

Not Applicable

Recruiting

Conditions: Appendicitis

Interventions: Other: Drainage or antibiotics
Procedure: Operative management

First Posted Date: 2019-11-19

Last Posted Date: 2023-10-24

Lead Sponsor: Yale University

Target Recruit Count: 180

Registration Number: NCT04168866

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

TMZ + Olaparib for MGMT Hypermethylated Colorectal Cancer

Phase 2

Completed

Conditions: Colorectal Cancer

Interventions: Drug: Temozolomide + Olaparib

First Posted Date: 2019-11-18

Last Posted Date: 2023-09-06

Lead Sponsor: Yale University

Target Recruit Count: 11

Registration Number: NCT04166435

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Pilot: Feasibility of Intermittent Enteral Feeding in Ventilated MICU Patients

Not Applicable

Completed

Conditions: Nutrition

Interventions: Dietary Supplement: Intermittent Enteral Nutrition Protocol

First Posted Date: 2019-11-15

Last Posted Date: 2021-05-25

Lead Sponsor: Yale University

Target Recruit Count: 14

Registration Number: NCT04164108

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States
🇺🇸
Yale New Haven Hospital, York Street Campus, New Haven, Connecticut, United States

Comparing a Fatherhood Focused Individual Intervention to Batterer Intervention to Reduce IPV and Child Maltreatment

Not Applicable

Completed

Conditions: Intimate Partner Violence

Interventions: Behavioral: F4C
Behavioral: BIP

First Posted Date: 2019-11-15

Last Posted Date: 2024-04-04

Lead Sponsor: Yale University

Target Recruit Count: 60

Registration Number: NCT04165291

Locations: 🇺🇸
Carla Stover, Hamden, Connecticut, United States

Imaging Glutamate Release From Alcohol

Early Phase 1

Completed

Conditions: Alcohol Drinking

Interventions: Drug: Alcohol

First Posted Date: 2019-11-12

Last Posted Date: 2024-10-09

Lead Sponsor: Yale University

Target Recruit Count: 8

Registration Number: NCT04159688

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy